- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.04 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 8 residues within 4Å:- Chain C: S.223, E.225, P.226, L.275, N.276, N.389, S.454, S.455
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.8: 11 residues within 4Å:- Chain E: E.225, P.226, V.268, L.275, N.276, N.389, C.390, G.391, S.454, S.455
- Ligands: NAG-NAG.7
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:G.391, E:S.454
NAG-NAG-BMA-MAN-MAN.11: 9 residues within 4Å:- Chain F: E.225, V.268, L.275, N.276, N.389, G.391, S.454, S.455
- Ligands: NAG.40
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:S.454
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 2 residues within 4Å:- Chain C: N.315, Q.450
Ligand excluded by PLIPNAG.13: 5 residues within 4Å:- Chain C: E.307, N.309, N.345, S.347
- Ligands: NAG.14
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain C: N.345, N.421
- Ligands: NAG.13
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain C: S.305, S.454, S.455, N.456
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain C: S.172, F.173, N.174
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain C: N.136, T.138, N.203
Ligand excluded by PLIPNAG.18: 6 residues within 4Å:- Chain C: V.196, P.197, I.198, R.206, L.207, N.211
Ligand excluded by PLIPNAG.19: 6 residues within 4Å:- Chain C: G.378, G.379, V.384, M.385, N.398, T.400
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain C: N.243, N.255
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain E: N.315, I.336, Q.450
Ligand excluded by PLIPNAG.22: 7 residues within 4Å:- Chain E: E.307, N.309, N.345, I.346, S.347
- Ligands: NAG-NAG.6, NAG-NAG.6
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain E: S.172, F.173, N.174, K.185
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain E: N.136
Ligand excluded by PLIPNAG.25: 6 residues within 4Å:- Chain E: V.196, R.206, L.207, N.209, N.211, T.212
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain E: N.244, T.246, T.254, N.255
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain E: E.283, N.303, K.357
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain E: N.352, S.405, W.407
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain E: V.384, M.385, N.398, T.400
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain E: T.400, N.404
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain E: N.410, E.411
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain E: N.290, T.292, D.293
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain E: N.248, T.250, S.288, E.289
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain F: N.211, T.212
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain F: T.134, S.172, N.174
Ligand excluded by PLIPNAG.36: 6 residues within 4Å:- Chain F: N.244, T.246, F.247, N.248, T.254
- Ligands: NAG.37
Ligand excluded by PLIPNAG.37: 6 residues within 4Å:- Chain F: N.248, T.250, S.288, E.289, F.291
- Ligands: NAG.36
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain F: N.290, T.292, D.293
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain F: E.282, I.284, N.303, K.357
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain F: S.305, S.454, N.456
- Ligands: NAG-NAG-BMA-MAN-MAN.11
Ligand excluded by PLIPNAG.41: 7 residues within 4Å:- Chain F: E.307, N.309, N.345, I.346, S.347, S.454
- Ligands: NAG.42
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain F: N.345, N.421
- Ligands: NAG.41, NAG.43
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain F: H.343, N.345, N.421, T.423
- Ligands: NAG.42
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain F: N.315, I.336, Q.450
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain F: V.384, M.385, N.398, T.400
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain F: T.400, Q.401, N.404
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain F: Y.408, N.410
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain F: E.93, N.94
- Chain H: G.13, S.17
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain G: Q.141, N.145
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain G: N.100, T.102
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain G: N.110, N.114
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain G: N.105
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain G: K.122, E.123, N.126
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain H: K.122, E.123, N.126
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain H: Q.141, N.145
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RQk-FP-A pAb heavy chain: A
RQk-FP-A pAb light chain: B
AMC016 v4.2 envelope glycoprotein gp120: CEF
AMC016 v4.2 transmembrane protein gp41: DGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CF
DD
GG
EH
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.04 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 7 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RQk-FP-A pAb heavy chain: A
RQk-FP-A pAb light chain: B
AMC016 v4.2 envelope glycoprotein gp120: CEF
AMC016 v4.2 transmembrane protein gp41: DGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AE
CF
DD
GG
EH
F